Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
about
Down syndrome and leukemia: insights into leukemogenesis and translational targetsThe biology of pediatric acute megakaryoblastic leukemiaPrognosis and management of acute myeloid leukemia in patients with Down syndromeMyeloid leukemia in Down syndromeRegulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in miceGermline genomic variants associated with childhood acute lymphoblastic leukemiaCalpain 2 activation of P-TEFb drives megakaryocyte morphogenesis and is disrupted by leukemogenic GATA1 mutationCross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.A statistical framework for consolidating "sibling" probe sets for Affymetrix GeneChip data.Treatment and prognostic impact of transient leukemia in neonates with Down syndromeThe OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus.Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.The prenatal origins of cancerGATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.Differential coregulator requirements for function of the hematopoietic transcription factor GATA-1 at endogenous lociPerturbed hematopoiesis in the Tc1 mouse model of Down syndrome.Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesisA unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.A knock-in Npm1 mutation in mice results in myeloproliferation and implies a perturbation in hematopoietic microenvironmentDown syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathologyTranscriptional control of erythropoiesis: emerging mechanisms and principles.Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.GATA Transcription Factors and Cancer.Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS)DFLAT: functional annotation for human development.ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndromeDifferential sensitivities of transcription factor target genes underlie cell type-specific gene expression profiles.Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.Metagene projection for cross-platform, cross-species characterization of global transcriptional statesIncreased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis.Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) studyCharacterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndromeMyeloid Proliferations Associated with Down Syndrome.
P2860
Q26770335-7BFC8316-C952-4D19-AA72-B79A4C81087DQ26799478-AC05C72E-89B1-45D5-8457-24375089EDAEQ27016577-B076DEB1-C2CB-4E44-A3EF-8B1A1A56F2C8Q27027258-CB65AE8C-4575-4B80-A2C4-3832F10F54A5Q28388916-7BACC951-B5B7-4172-99B4-2FC9889B15ECQ28924384-8F0116A2-21E0-4F3D-B562-FDEAC6D70BF0Q30409004-2E38EE22-A7DF-42A0-9EB8-2FFB268C6B46Q30437637-B29573C2-C999-4F99-8F23-3B99EDA61423Q30437922-3AA4A757-2741-4C94-AF12-E29988FCDBC2Q31153601-95A98281-BA93-482E-B1BE-5B41D027D61EQ33378192-C457FAC7-0AC5-43E9-8C7C-394C11E95F14Q33383707-9AB2FB88-C24A-496B-A2F5-806FF6871F3AQ33526661-751AEC1B-3C41-40C7-8290-B1DC5A97312CQ33538325-DDFE165F-C008-4622-8B3D-49A7447187B7Q33685173-B323E195-9C60-4124-B6FD-2F53F718D691Q33697463-14CF7BC8-8001-41A4-80D6-9CCA810343B9Q33717768-C5CA5749-6FD4-4223-BC1F-5DEFC0E9ECAAQ33783137-3C2F70F0-2543-4A90-BB02-1BDCFEC9519DQ33788720-8EA897CC-F76B-4790-95CC-72655087F436Q34030154-CB73C770-3554-4F09-9892-AB9A14F4FB1CQ34081566-53994653-5570-4523-9B4E-94CDA490C68CQ34505038-5A6F975B-EB60-4526-8F8A-E102B9FD0B9BQ34611232-A467886A-C176-4AA1-BE5D-38E264CB047AQ34700755-FD48411F-8125-47A5-B0E9-E0B0B1301CE6Q34750189-1D348B2E-E774-412F-8F3B-82ACA27FF350Q34972814-4A03A303-B9A9-4CDC-A71A-646A4A287E1FQ35005153-9C66177C-967D-48E6-9157-7533DC9AA392Q35089024-43D9DD9B-B52D-4436-9D2E-F9F986A67290Q35101250-6750C0E3-574B-4BDC-8905-16ECF56F6ADDQ35103552-5FEDC00F-7047-466A-860A-EAE25F204DE7Q35127556-3AC07D72-3718-4407-A6C0-4250CCA46DA8Q35144992-12ACA800-13AD-455E-9027-260656C0AE81Q35719918-6EE0E702-7475-4F79-8EA5-4D2AE7E9A292Q35780831-5D4A1E39-9FDB-4290-846E-69C30DB2BEFFQ35909653-6D34C04A-A2DC-4713-8694-4C81727F8455Q36002170-548E22EB-8995-4F82-9478-DB96A081244CQ36340868-F7EAF46F-6355-438C-A3B2-1C3C775F119CQ36378527-229037DE-D0A8-4B97-8106-E3EC5A324EE6Q36384719-69693E08-D208-4E1E-A4CB-70E9D82C6722Q36440331-2E97A2CF-C574-45FF-ACD6-99B558C6EE87
P2860
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of distinct mol ...... by gene expression profiling.
@ast
Identification of distinct mol ...... by gene expression profiling.
@en
Identification of distinct mol ...... by gene expression profiling.
@nl
type
label
Identification of distinct mol ...... by gene expression profiling.
@ast
Identification of distinct mol ...... by gene expression profiling.
@en
Identification of distinct mol ...... by gene expression profiling.
@nl
prefLabel
Identification of distinct mol ...... by gene expression profiling.
@ast
Identification of distinct mol ...... by gene expression profiling.
@en
Identification of distinct mol ...... by gene expression profiling.
@nl
P2093
P2860
P50
P356
P1476
Identification of distinct mol ...... a by gene expression profiling
@en
P2093
André Baruchel
Aravind Subramanian
Christian M Zwaan
Claudia Langebrake
Dirk Reinhardt
Elisabeth van Wering
Gertjan L Kaspers
Lucienne Michaux
Michel Lessard
Nicole Dastugue
P2860
P304
P356
10.1073/PNAS.0511150103
P407
P577
2006-02-21T00:00:00Z